Drug Discovery

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

How can we maximize the potential and production of potentially life-saving therapies?

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.

Andes-based cannabis cultivator Clever Leaves pledges to send US$25 million of leaves to US researchers.

A husband-and-wife-led team used mass spec to identify new drugs that “glue” proteins together. We spoke to Aneika Leney about the project.

It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.